News Biomarker hailed as “game changer” in Parkinson’s Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated.
News FDA rejects AbbVie’s continuous Parkinson’s therapy Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
News Digital tech assessed in BlueRock Parkinson’s trial Devices that remotely monitor patients' mobility and sleep will be put through their paces.
Digital Newel Health begins next phase of development of Soturi Soturi, Newel Health’s digital therapeutics solution for Parkinson’s Disease (PD), has begun the next phase of development, aiming to v
Digital Newel Health scores $2.5M from MJFF for Parkinson’s app Newel Health has been awarded a $2.5 million USD grant from the Michael J.
Digital Partner Content Newel Health awarded $2.5M Michael J. Fox research grant Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.